Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.92% |
| 2 | Healthcare | 2.55% |
| 3 | Industrials | 2.24% |
| 4 | Financials | 2.13% |
| 5 | Consumer Discretionary | 1.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
PUT
Quest Diagnostics
DGX
$25.9B
| $11.7M | ﹤0.01% |
55,200
+25,900
| +88% | +$5.08M |
|
3277
CALL
Exelon
EXC
$47.2B
| $11.7M | ﹤0.01% |
250,500
-190,300
| -43% | -$8.8M |
|
|
EROK
3278
EagleRock Land
EROK
$612M
| $11.7M | ﹤0.01% |
+549,394
| New | +$11.9M |
|
3279
Hawaiian Electric Industries
HE
$2.03B
| $11.7M | ﹤0.01% |
862,812
+655,876
| +317% | +$9.35M |
|
3280
PUT
Truist Financial
TFC
$64.9B
| $11.7M | ﹤0.01% |
234,300
-37,300
| -14% | -$1.83M |
|
3281
PUT
Ambarella
AMBA
$3.6B
| $11.7M | ﹤0.01% |
136,000
+105,100
| +340% | +$7.23M |
|
3282
CALL
InterDigital
IDCC
$8.87B
| $11.7M | ﹤0.01% |
41,200
+16,700
| +68% | +$4.97M |
|
3283
CytomX Therapeutics
CTMX
$732M
| $11.7M | ﹤0.01% |
3,110,509
-2,295,684
| -42% | -$8.77M |
|
3284
Orion Group Holdings
ORN
$402M
| $11.7M | ﹤0.01% |
693,401
+406,573
| +142% | +$5.62M |
|
3285
PPG Industries
PPG
$25.4B
| $11.7M | ﹤0.01% |
96,134
+33,884
| +54% | +$3.77M |
|
3286
National Vision
EYE
$1.53B
| $11.7M | ﹤0.01% |
613,099
-39,769
| -6% | -$811K |
|
3287
CALL
Wendy's
WEN
$1.65B
| $11.7M | ﹤0.01% |
1,405,500
+1,032,800
| +277% | +$7.38M |
|
|
DQ
3288
PUT
Daqo New Energy
DQ
$991M
| $11.6M | ﹤0.01% |
869,500
+769,500
| +770% | +$14M |
|
3289
Forte Biosciences
FBRX
$1.63B
| $11.6M | ﹤0.01% |
547,415
+314,046
| +135% | +$7.45M |
|
3290
LXP Industrial Trust
LXP
$3.57B
| $11.6M | ﹤0.01% |
215,852
-734,423
| -77% | -$37.8M |
|
|
BPRE
3291
Bluerock Private Real Estate Fund
BPRE
| $11.6M | ﹤0.01% |
+893,749
| New | +$13.9M |
|
3292
PUT
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.24B
| $11.6M | ﹤0.01% |
+172,900
| New | +$11.6M |
|
3293
Credit Acceptance
CACC
$6.1B
| $11.6M | ﹤0.01% |
18,256
+8,893
| +95% | +$4.76M |
|
3294
Nordson
NDSN
$17.2B
| $11.6M | ﹤0.01% |
38,528
-36,754
| -49% | -$10.4M |
|
|
NOVTU
3295
Novanta Inc Units
NOVTU
$760M
| $11.6M | ﹤0.01% |
170,090
-499,910
| -75% | -$31.3M |
|
3296
CALL
Incyte
INCY
$24.4B
| $11.6M | ﹤0.01% |
102,400
+54,600
| +114% | +$5.41M |
|
3297
CALL
Stride
LRN
$3.46B
| $11.6M | ﹤0.01% |
134,500
+47,400
| +54% | +$4.36M |
|
3298
ABM Industries
ABM
$2.82B
| $11.6M | ﹤0.01% |
262,142
-259,797
| -50% | -$10.7M |
|
3299
United States Antimony
UAMY
$825M
| $11.6M | ﹤0.01% |
1,597,364
+1,193,119
| +295% | +$10.8M |
|
|
HNGE
3300
CALL
Hinge Health
HNGE
$7.14B
| $11.6M | ﹤0.01% |
139,700
+77,200
| +124% | +$4.19M |
|
Similar funds
Ken Griffin's Q2 2026 Portfolio in Review
As of Q2 2026, Ken Griffin held 15,447 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $103B of net new capital in Q2 2026, opening 2,575 new positions and adding to 6,089 existing holdings. Its largest new stake was SpaceX: 5,129,884 shares worth $876M.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, down from 4.5% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Micron Technology, an estimated $3B trimmed.
- Ken Griffin's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Ken Griffin's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Ken Griffin fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Ken Griffin's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Ken Griffin opened 2,575 new positions and closed 1,872 in Q2 2026.
- Ken Griffin's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.